MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pusch, M.
Right arrow Articles by Camerino, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pusch, M.
Right arrow Articles by Camerino, D. C.

Vol. 58, Issue 3, 498-507, September 2000

Pharmacological Characterization of Chloride Channels Belonging to the ClC Family by the Use of Chiral Clofibric Acid Derivatives

Michael Pusch, Antonella Liantonio,1 Lara Bertorello, Alessio Accardi, Annamaria De Luca, Sabata Pierno, Vincenzo Tortorella, and Diana Conte Camerino

Istituto di Cibernetica e Biofisica, CNR, Genova (M.P., A.L., L.B., A.A.); and Unità di Farmacologia, Dipartimento Farmacobiologico (A.D.L., S.P., D.C.C.) and Dipartimento Farmacochimico (V.T.), Università di Bari, Bari, Italy

The enantiomers of 2-(p-chlorophenoxy)propionic acid (CPP) and of its analogs with substitutions on the asymmetric carbon atom were tested on human ClC-1 channel, the skeletal muscle chloride channel, after heterologous expression in Xenopus laevis oocytes, to gain insight in the mechanism of action of these stereoselective modulators of macroscopic chloride conductance (gCl) of rat striated fibers. By means of two microelectrode voltage clamp recordings, we found that S(-)-CPP shifted the activation curve of the ClC-1 currents toward more positive potentials and decreased the residual conductance at negative membrane potential; both effects probably account for the decrease of gCl at resting potential of native muscle fibers. Experiments on expressed Torpedo marmorata ClC-0 channels and a mutant lacking the slow gate suggest that S(-)-CPP could act on the fast gate of the single protochannels constituting the double-barreled structure of ClC-0 and ClC-1. The effect of S(-)-CPP on ClC-1 was markedly increased at low external pH (pH = 6), possibly for enhanced diffusion through the membrane (i.e., because the compound was effective only when applied to the cytoplasmic side during patch clamp recordings). The R(+)-isomer had little effect at concentrations as high as 1 mM. The CPP analogs with an ethyl, a phenyl, or an n-propyl group in place of the methyl group on the asymmetric center showed a scale of potency and a stereoselective behavior on ClC-1 similar to that observed for blocking gCl in native muscle fibers. The tested compounds were selective toward the ClC-1 channel. In fact, they were almost ineffective on an N-terminal deletion mutant of ClC-2 that is volume- and pH-independent while they blocked wild-type ClC-2 currents only at high concentrations and independently of pH and drug configuration, suggesting a different mechanism of action compared with ClC-1. No effects were observed on ClC-5 that shows less than 30% homology with ClC-1. Thus, CPP-like compounds may be useful both to gain insight into biophysical properties of ClC-1 and for searching tissue-specific therapeutic agents.


1 Permanent address: Unità di Farmacologia, Dipartimento Farmacobiologico, Università di Bari, Bari, Italy.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
JGPHome page
X.-D. Zhang, P.-Y. Tseng, W.-P. Yu, and T.-Y. Chen
Blocking Pore-open Mutants of CLC-0 by Amphiphilic Blockers
J. Gen. Physiol., December 29, 2008; 133(1): 43 - 58.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
X.-D. Zhang and T.-Y. Chen
Amphiphilic Blockers Punch through a Mutant CLC-0 Pore
J. Gen. Physiol., December 29, 2008; 133(1): 59 - 68.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
G. Zifarelli, A. R. Murgia, P. Soliani, and M. Pusch
Intracellular Proton Regulation of ClC-0
J. Gen. Physiol., July 1, 2008; 132(1): 185 - 198.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Liantonio, A. Picollo, G. Carbonara, G. Fracchiolla, P. Tortorella, F. Loiodice, A. Laghezza, E. Babini, G. Zifarelli, M. Pusch, et al.
Molecular switch for CLC-K Cl- channel block/activation: Optimal pharmacophoric requirements towards high-affinity ligands
PNAS, January 29, 2008; 105(4): 1369 - 1373.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Liantonio, A. Picollo, E. Babini, G. Carbonara, G. Fracchiolla, F. Loiodice, V. Tortorella, M. Pusch, and D. C. Camerino
Activation and Inhibition of Kidney CLC-K Chloride Channels by Fenamates
Mol. Pharmacol., January 1, 2006; 69(1): 165 - 173.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
M Pusch, G Zifarelli, A. R Murgia, A Picollo, and E Babini
Channel or transporter? The CLC saga continues
Exp Physiol, January 1, 2006; 91(1): 149 - 152.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
S. Traverso, G. Zifarelli, R. Aiello, and M. Pusch
Proton Sensing of CLC-0 Mutant E166D
J. Gen. Physiol., December 27, 2005; 127(1): 51 - 66.
[Abstract] [Full Text] [PDF]


Home page
Chem SensesHome page
R. E. Doolin and B. W. Ache
Cyclic Nucleotide Signaling Mediates an Odorant-suppressible Chloride Conductance in Lobster Olfactory Receptor Neurons
Chem Senses, February 1, 2005; 30(2): 127 - 135.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Liantonio, M. Pusch, A. Picollo, P. Guida, A. De Luca, S. Pierno, G. Fracchiolla, F. Loiodice, P. Tortorella, and D. C. Camerino
Investigations of Pharmacologic Properties of the Renal CLC-K1 Chloride Channel Co-expressed with Barttin by the Use of 2-(p-Chlorophenoxy)Propionic Acid Derivatives and Other Structurally Unrelated Chloride Channels Blockers
J. Am. Soc. Nephrol., January 1, 2004; 15(1): 13 - 20.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
S. Traverso, L. Elia, and M. Pusch
Gating Competence of Constitutively Open CLC-0 Mutants Revealed by the Interaction with a Small Organic Inhibitor
J. Gen. Physiol., August 25, 2003; 122(3): 295 - 306.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
A. Accardi and M. Pusch
Conformational Changes in the Pore of CLC-0
J. Gen. Physiol., August 25, 2003; 122(3): 277 - 294.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Liantonio, A. Accardi, G. Carbonara, G. Fracchiolla, F. Loiodice, P. Tortorella, S. Traverso, P. Guida, S. Pierno, A. De Luca, et al.
Molecular Requisites for Drug Binding to Muscle CLC-1 and Renal CLC-K Channel Revealed by the Use of Phenoxy-Alkyl Derivatives of 2-(p-Chlorophenoxy)Propionic Acid
Mol. Pharmacol., August 1, 2002; 62(2): 265 - 271.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Pierno, J.-F. Desaphy, A. Liantonio, M. De Bellis, G. Bianco, A. De Luca, A. Frigeri, G. P. Nicchia, M. Svelto, C. Leoty, et al.
Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse
Brain, July 1, 2002; 125(7): 1510 - 1521.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. J. Jentsch, V. Stein, F. Weinreich, and A. A. Zdebik
Molecular Structure and Physiological Function of Chloride Channels
Physiol Rev, April 1, 2002; 82(2): 503 - 568.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Accardi, L. Ferrera, and M. Pusch
Drastic reduction of the slow gate of human muscle chloride channel (ClC-1) by mutation C277S
J. Physiol., August 1, 2001; 534(3): 745 - 752.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. C. Aromataris, G. Y. Rychkov, B. Bennetts, B. P. Hughes, A. H. Bretag, and M. L. Roberts
Fast and Slow Gating of CLC-1: Differential Effects of 2-(4-Chlorophenoxy) Propionic Acid and Dominant Negative Mutations
Mol. Pharmacol., July 1, 2001; 60(1): 200 - 208.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics